Sulfinpyrazone

Sulfinpyrazone (G-28315) is an orally active and potent uricosuric agent for chronic and intermittent gouty arthritis. Sulfinpyrazone has antithrombotic and platelet inhibitory effects[1][2].

Product Specifications

CAS Number

[57-96-5]

Product Name Alternative

G-28315

UNSPSC

12352005

Hazard Statement

H302

Target

Endogenous Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/sulfinpyrazone.html

Purity

98.08

Solubility

DMSO : 33.33 mg/mL (ultrasonic)

Smiles

O=C(C1CCS(C2=CC=CC=C2)=O)N(C3=CC=CC=C3)N(C4=CC=CC=C4)C1=O

Molecular Formula

C23H20N2O3S

Molecular Weight

404.48

Precautions

H302

References & Citations

[1]Margulies EH, White AM, Sherry S. Sulfinpyrazone: a review of its pharmacological properties and therapeutic use. Drugs. 1980;20 (3) :179‐197.|[2]Rüegg M. Antithrombotic effects of sulfinpyrazone in animals: influence on fibrinolysis and sodium arachidonate-induced pulmonary embolism. Pharmacology. 1976;14 (6) :522‐536.